Real World Evidence with Debritom+ for Chronic Wounds
This study is looking at how well a new device, debritom+, works for treating chronic wounds like diabetic foot ulcers, venous leg ulcers, surgical wounds that have opened up (dehiscence), and traumatic wounds. Debritom+ uses a micro water jet to clean wounds. Researchers will compare it to the standard way of cleaning wounds, which is using a sharp scalpel. The main goal is to see how many wounds close completely after 20 weeks. You might be able to join if you are at least 18 years old and have a wound that has been present for more than 4 weeks but less than a year. The current recruitment status is unclear.
- Study design
- This is a single-center, randomized controlled trial that plans to enroll 180 participants. It is single-blinded, meaning you wouldn't know which treatment you're receiving.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Wound closure will be measured at 20 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Melvin B Price, DPM · PRINCIPAL_INVESTIGATOR · MCR Health Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Wound Closure20 weeks
Time to heal